Table 1: Demographic and pre injection IVO clinical characteristics of patients.

n

Age

years

Gender

f: female

m: male

Eye

r: right

l: left

Lens

p: phakic

pp: pseudophakic

ap: aphakic

Duration time

months

Anti-inflammatory topical therapy

1

62

f

r

pp

3

steroid

2

58

m

r

p

4

--

3

89

m

l

pp

45

bromfenac

4

89

m

r

pp

45

bromfenac

5

65

m

r

p

12

prednisolone acetate ophthalmic suspension (steroid)

6

76

f

r

pp

7

nepafenac ophthalmic suspension (NSAID)

7

77

m

l

pp

4

indometacine

descriptive analysis

Mean

73.71 ± 2.53

range 58 -89

 

2 (28.6%) f

5 (71.4%) m

5(71.4%) r

2 (28.6%) l

2 (28.6%) p

571.4(%) pp

Mean

17.14 ± 19.26

range 3 - 45

2 (28.6%) steroids

2 (28.6%) bromfenac

1 (14.3%) nepafanac

1 (14.3%) indometacine

1 (14.3%) ---